13 Results for "

coagulation factor XIa

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "coagulation factor XIa" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-137431
CAS No.: 2064121-65-7
Purity:  99.80%
Synonyms: BAY-2433334
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Asundexian (BAY 2433334) is an orally active coagulation factor Xia (FXIa) inhibitor. Asundexian binds directly, potently, and reversibly to the active site of FXIa and thereby inhibits its activity. Asundexian inhibits human FXIa in buffer with an IC50 of 1 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-125856
CAS No.: 1802425-99-5
Purity:  99.93%
Synonyms: BMS-986177; JNJ-70033093
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Milvexian is an orally bioavailable, small-molecule, reversible, direct antagonists of factor Xia, with the Ki of 0.11, 0.38, 0.64, 490, 350 nM for human, rabbit, dog, rat, mouse, respectively. Milvexian shows anti-thrombosis activity in vitro and in vivo, and can be used for thrombus study .
loading...
    loading...
Cat. No.: HY-156613
CAS No.: 1803270-60-1
Purity:  97.16%
Synonyms: EP-7041
Target:  

Factor XI

Research Areas:  

Infection

Frunexian (EP-7041) is a selective and potent inhibitor of coagulation factor XI/activated factor XI, targeting to factor XIa. Frunexian exhibits antithrombotic activity, with no bleeding liability in rat mesenteric arterial puncture model. Frunexian can be used in extracorporeal membrane oxygenation (ECMO) research .
loading...
    loading...
Cat. No.: HY-P4331
CAS No.: 113865-85-3
Research Areas:  

Cardiovascular Disease

Boc-Gln-Gly-Arg-AMC is a fluorogenic substrate for kallikrein (PKa), coagulation factor XIIa (FXIIa) and coagulation factor XIa (FXIa). Boc-Gln-Gly-Arg-AMC enables fluorescence-based activity assays for PKa, FXIIa and FXIa .
loading...
    loading...
Cat. No.: HY-P4332
CAS No.: 113866-16-3
Research Areas:  

Cardiovascular Disease

Boc-Glu(OBzl)-Ala-Arg-AMC is a fluorogenic substrate for coagulation factor XIa and trypsin. The cleavage of the amide bond between arginine and the methylcoumarin amide group releases fluorescent 7-Amino-4-methylcoumarin (HY-D0027) .
loading...
    loading...
Cat. No.: HY-150519
CAS No.: 1551460-43-5
Target:  

Factor XI Kallikrein

Research Areas:  

Cardiovascular Disease

FXIa/Plasma kallikrein-IN-1 is an inhibitor of coagulation factor XIa (FXIa) and plasma kallikrein with Ki values of 187.70 nM and 151.6 nM, respectively. FXIa/Plasma kallikrein-IN-1 can be used in the research of thromboembolic diseases .
loading...
    loading...
Cat. No.: HY-172400
CAS No.: 3046390-69-3
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

FXIa-IN-16 is an orally active selective FXIa inhibitor with an IC50 of 0.19 nM. FXIa-IN-16 exerts highly selective competitive inhibition on endogenous FXIa, blocks the thrombin amplification loop to inhibit thrombosis, while preserving exogenous physiological hemostatic function. FXIa-IN-16 can be used in thrombosis-related research .
loading...
    loading...
Cat. No.: HY-125856A
CAS No.: 1802426-00-1
Synonyms: BMS-986177 TFA; JNJ-70033093 TFA
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Milvexian TFA (BMS-986177 TFA) is a factor XIa inhibitor with biological activity to prevent venous thromboembolism. Milvexian TFA was effective in reducing the occurrence of venous thromboembolism in patients undergoing knee replacement surgery. Milvexian TFA has good selectivity and shows significant inhibitory effects on plasma kallikrein and trypsin. Milvexian TFA has a bioavailability of 32%, which means it has a high absorption rate in the body. Milvexian TFA showed a relatively low risk of bleeding in clinical trials .
loading...
    loading...
Cat. No.: HY-E70393J
Target:  

Factor XI

Research Areas:  

Others

Bovine Factor XIa is an enzyme, which is involved in the intrinsic pathway of blood coagulation. Bovine Factor XIa is highly selective and exhibits a minimal extended substrate recognition site of at least five residues long. Bovine Factor XIa is reactive as Bovine Factor IXa (HY-E70393I) does, that it cleaves all the peptides bearing factor IX activation site sequences .
loading...
    loading...
Cat. No.: HY-P4333
CAS No.: 73554-94-6
Target:  

Fluorescent Dye

Research Areas:  

Cardiovascular Disease

Boc-Glu(OBzl)-Gly-Arg-AMC is a fluorogenic substrate for factors IXa and XIIa. The cleavage of the amide bond between arginine and the methylcoumarin amide group releases fluorescent 7-Amino-4-methylcoumarin (HY-D0027) .
loading...
    loading...
Cat. No.: HY-117290A
CAS No.: 1430115-97-1
Target:  

Factor XI

Research Areas:  

Cardiovascular Disease

BMS-962212 hydrochloride is a selective coagulation factor XIa inhibitor and acute antithrombotic agent. BMS-962212 hydrochloride can be used in the research of thrombosis .
loading...
    loading...
Cat. No.: HY-137431S
CAS No.: 2975248-62-3
Synonyms: BAY-2433334-d3
Asundexian-d3 (BAY-2433334-d3) is the deuterium labeled Asundexian (HY-137431). Asundexian (BAY 2433334) is an orally active coagulation factor Xia (FXIa) inhibitor. Asundexian binds directly, potently, and reversibly to the active site of FXIa and thereby inhibits its activity. Asundexian inhibits human FXIa in buffer with an IC50 of 1 nM .
loading...
    loading...
Cat. No.: HY-183409
CAS No.: 1941243-22-6
Synonyms: ONO-5450598
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

ONO-7684 (ONO-5450598) is an orally active coagulation factor XIa (FXIa) inhibitor with a Ki value of 2 nM against human FXIa. ONO-7684 inhibits human FXIa in a competitive and reversible manner, reduces factor XI coagulation activity, prolongs activated partial thromboplastin time in a dose-dependent manner, and exerts no significant effects on PT/INR and the activity of related serine proteases. ONO-7684 exerts antithrombotic effects in vivo without prolonging bleeding time. ONO-7684 can be used in studies related to thromboembolic diseases .
loading...
    loading...
  • 1